| Application no. and date | 16729258.0 (espacenet) (Federated) (European Patent Register), 20160614 | | Patent/reg. no. and date | DK/EP 3310331, 20201014 | | Publication date | 20180425 | | Priority no. and date | US 201562180871 P, 20150617 | | EP pub. no. and date |
EP 3310331 20180425 | | Effective date | | | Applicant/owner | Nabriva Therapeutics GMBH, Leberstraße 20
1110 Wien, AT | | Applicant ref. no. | V51274DK00 | | Inventor | Heilmayer, Werner, Obere Weideäcker 19
7034 Zillingtal, AT,
FERENCIC, Mathias, Adalbert-Stifter-Gasse 18-20
3400 Klosterneuburg, AT,
HINSMANN, Peter, Petrusgasse 9/15
1030 Wien, AT,
WICHA, Wolfgang, Dr. Otto Tschadek Strasse 17
2460 Bruck an der Leitha, AT | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/215 (2006.01) , A61K 47/02 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 31/04 (2006.01) | | Title | Injicerbare farmaceutiske formuleringer af lefamulin | | Int. application no. | EP2016063609 | | Int. publication no. | WO2016202788 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
